Technologies
SOLX™ TECHNOLOGY
The SOLX™ System with CPD Anticoagulant and SOLX™ Solution is intended for the collection and leukoreduction of
500 mL CPD Whole Blood and subsequent processing of into Red Blood Cells and plasma:
- The SOLX™ Solution* (synonymous with AS-7) is the only RBC additive solution approved in the US for the preparation of RBCs from WB held at room temperature for up to 24 hours.
- The SOLX™ System is the only manual system approved in the US for the preparation of plasma from WB held at room temperature for up to 24 hours.
LEUP™ Leukoreduction Processing Circuits
Conventional leukoreduction sets require two or three manual steps using vents, check valves and/or valves to accomplish the filtration of blood products. HEMERUS’ LEUP™ processing circuit technology enables leukoreduction of blood products in an easy ONE STEP™ vent-free process. Operators simply hang the LEUP™ set, initiate flow, and walk away. LEUP™ processing circuit technology improves overall efficiency and frees up operators' labor and time, allowing them to perform other tasks during the filtration process. LEUP™ processing circuit technology is particularly beneficial for units processed in cold environments, such as walk-in refrigerators
LEUKOSEP™ Leukocyte Reduction Filter
Hemerus' LEUKOSEP™ leukocyte reduction filters* are designed to effectively remove leukocytes from blood and blood products. The self-priming LEUKOSEP™ filters provide high efficiency leukoreduction with low residual hold up, making the filtration process rapid and effortless.